Background: Potentially Inappropriate Medications (PIMS) use in older people is common and associated with poorer health outcomes. Many PIMS are associated with cognitive decline and are a potential reversible cause of cognitive impairment. However the frequency of PIMS use in the memory clinic setting at the point of referral is not well studied. Methods: A database of all patients referred to our memory clinic from January 2013-April 2017 was created. Demographic data, medications, cognitive assessments, and diagnosis for all patients were recorded retrospectively. The presence of polypharmacy (5-9 medications), hyper-polypharmacy (≥9 medications), Anticholinergic Burden (ACB) Score and PIMS for cognition as defined by Beers and STOPP criteria was recorded for all patients with a formal cognitive diagnosis. Patients with no evidence of cognitive impairment were excluded. Results: 277 patients with a formal cognitive diagnosis were identified (50.9% female, mean age 77.0 (IQR 73-82)). The mean Addenbrooke's Cognitive Examination, MiniMental State Exam, and Frontal Assessment Battery scores were 67.6 (IQR 59-78), 23.3 (IQR 20-27) and 12.8 (IQR 10-16) respectively. 32.5% (n = 90) of patients were diagnosed with mild cognitive impairment and 67.5% (n = 187) with dementia. Polypharmacy was present in 47.7% (n = 132) and 17.0% (n = 47) had hyperpolypharmacy. 15.2% (n = 42) of patients had a clinically significant ACB score of ≥3. 20.7% (n = 57) of patients had ≥1 PIM as defined by STOPP criteria. 27.4% (n = 76) had ≥1 PIM as defined by Beers criteria. The most commonly prescribed PIMS were non-benzodiazepine hypnotics (n = 26), benzodiazepines (n = 23) and bladder antimuscarinics (n = 20). Conclusion: We identified a high prevalence of polypharmacy, PIMS, and anticholinergic medication burden in patients with a formal cognitive diagnosis at the point of referral to a specialist memory clinic. Our results highlight the importance of addressing inappropriate prescribing in patients with cognitive disorders.
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